Moderna reports that it has received full approval from the U.S. Food and Drug Administration for its COVID-19 vaccine, Spikevax.

The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the vaccine maker said on Friday.

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in young children.

The FDA granted full approval to Moderna's COVID-19 vaccine (Spikevax) for kids ages 6 months through 11 years who are at increased risk of severe disease, the company announced.

Moderna’s CEO Stéphane Bancel celebrated the approval, writing, “COVID-19 continues to pose a significant potential threat to children, especially those with underlying medical conditions.

Only 39 people have received compensation from the federal program for COVID-19 vaccine injuries. It has rejected another 4,338 claims.

The price changes will impact multiple products in Hershey’s portfolio that are made with chocolate. Among the items expected to increase in price are Hershey Kisses, KitKat, Reese’s and York ...

Federal liability protections currently prevent people suing COVID-19 vaccine makers, and instead require them to request compensation from a program that's covered only 39 COVID vaccine injury ...

Phones Report hints at no price increase for the Snapdragon 8 Elite Gen 2 — and that's good news for the Galaxy S26 News By Scott Younker published July 21, 2025 ...

The head of Lucid Group Inc. warned that President Donald Trump’s tariffs will drive up costs to build automobiles — even in the US.